(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type
- PMID: 1955897
- PMCID: PMC1014518
- DOI: 10.1136/jnnp.54.9.787
(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type
Abstract
Regional cerebral perfusion was evaluated by single photon emission tomography (SPECT) using (99mTc)-HM-PAO as a tracer, in thirty Parkinsonian patients with (n = 15) or without (n = 15) dementia, nineteen patients with dementia of the Alzheimer type (DAT) and thirteen control subjects. HM-PAO uptake was measured in the frontal, parietal, temporal and occipital cortex and tracer perfusion was expressed as cortical/cerebellar activity ratios. Regional HM-PAO ratios in nondemented Parkinsonian patients did not differ from controls, whereas in demented patients with Parkinson's disease (DPD) a significant reduction was found in the parietal, temporal and occipital cortex. Tracer uptake ratios were significantly reduced in all regions in the DAT group. Thus DPD and DAT shared a common pattern of marked posterior hypoperfusion, although the perfusion defect was greater and more extensive in the DAT patients.
Comment in
-
(99mTc)-HM-PAO SPECT and dementia in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):981. doi: 10.1136/jnnp.55.10.981-b. J Neurol Neurosurg Psychiatry. 1992. PMID: 1431975 Free PMC article. No abstract available.
Similar articles
-
CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results.J Cereb Blood Flow Metab. 1988 Dec;8(6):S109-15. doi: 10.1038/jcbfm.1988.40. J Cereb Blood Flow Metab. 1988. PMID: 3263977
-
Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.Eur J Nucl Med. 1997 Mar;24(3):320-5. doi: 10.1007/BF01728771. Eur J Nucl Med. 1997. PMID: 9143472
-
A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.Eur J Nucl Med. 1991;18(1):3-11. doi: 10.1007/BF00177677. Eur J Nucl Med. 1991. PMID: 2019279
-
rCBF SPECT in Parkinson's disease patients with mental dysfunction.J Neural Transm Suppl. 1997;50:25-30. doi: 10.1007/978-3-7091-6842-4_3. J Neural Transm Suppl. 1997. PMID: 9120420 Review.
-
Functional brain imaging in late-life depression and dementia.J Clin Psychiatry. 1993 Nov;54 Suppl:21-5. J Clin Psychiatry. 1993. PMID: 8270594 Review.
Cited by
-
Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.Eur J Nucl Med. 1993 Apr;20(4):339-44. doi: 10.1007/BF00169811. Eur J Nucl Med. 1993. PMID: 8491227
-
Functional neuroimaging in Alzheimer's disease: how far should we go?Eur J Nucl Med. 1994 Oct;21(10):1041-3. doi: 10.1007/BF00181057. Eur J Nucl Med. 1994. PMID: 7828612 No abstract available.
-
Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.Eur J Nucl Med. 1994 Oct;21(10):1044-51. doi: 10.1007/BF00181058. Eur J Nucl Med. 1994. PMID: 7828613 Clinical Trial.
-
Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia.J Neurol. 1995 Jun;242(6):359-66. doi: 10.1007/BF00868390. J Neurol. 1995. PMID: 7561963
-
HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):180-5. doi: 10.1136/jnnp.57.2.180. J Neurol Neurosurg Psychiatry. 1994. PMID: 8126501 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical